Trial Profile
A Prospective, Randomised, Open-label study to evaluate the effect of Aliskiren on Aortic Stiffness in patients With Marfan Syndrome
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 31 Aug 2018
Price :
$35
*
At a glance
- Drugs Aliskiren (Primary)
- Indications Aortic aneurysm
- Focus Therapeutic Use
- 01 Sep 2018 Results published in the Revista Espanola de Cardiologia
- 31 Aug 2018 New trial record